Iron derived from autophagy-mediated ferritin degradation induces cardiomyocyte death and heart failure in mice.
Jumpei ItoShigemiki OmiyaMara-Camelia RusuHiromichi UedaTomokazu MurakawaYohei TanadaHajime AbeKazuki NakaharaMichio AsahiManabu TaneikeKazuhiko NishidaAjay M ShahKinya OtsuPublished in: eLife (2021)
Heart failure is a major public health problem, and abnormal iron metabolism is common in patients with heart failure. Although iron is necessary for metabolic homeostasis, it induces a programmed necrosis. Iron release from ferritin storage is through nuclear receptor coactivator 4 (NCOA4)-mediated autophagic degradation, known as ferritinophagy. However, the role of ferritinophagy in the stressed heart remains unclear. Deletion of Ncoa4 in mouse hearts reduced left ventricular chamber size and improved cardiac function along with the attenuation of the upregulation of ferritinophagy-mediated ferritin degradation 4 weeks after pressure overload. Free ferrous iron overload and increased lipid peroxidation were suppressed in NCOA4-deficient hearts. A potent inhibitor of lipid peroxidation, ferrostatin-1, significantly mitigated the development of pressure overload-induced dilated cardiomyopathy in wild-type mice. Thus, the activation of ferritinophagy results in the development of heart failure, whereas inhibition of this process protects the heart against hemodynamic stress.
Keyphrases
- heart failure
- iron deficiency
- wild type
- left ventricular
- public health
- cell death
- cardiac resynchronization therapy
- atrial fibrillation
- signaling pathway
- acute heart failure
- high fat diet induced
- high glucose
- endoplasmic reticulum stress
- type diabetes
- acute myocardial infarction
- diabetic rats
- oxidative stress
- hypertrophic cardiomyopathy
- metabolic syndrome
- mitral valve
- fatty acid
- acute coronary syndrome
- poor prognosis
- endothelial cells
- transcatheter aortic valve replacement
- insulin resistance
- angiotensin ii
- aortic stenosis
- anti inflammatory
- drug induced